Skip to content

Raymond J.m. Niesink

5 papers in the library · 252 citations · publishing 2005-2012

Papers

Sort Most recent Most cited

Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.

The International journal on drug policy March 2012 Tibor M Brunt, Raymond J M Niesink, Wim Van den Brink

A recent decline in MDMA-like substances in ecstasy tablets has been reported by a number of countries in the European Union. This study describes the instability of the ecstasy market in The Netherlands during 2008 and 2009, and investigates whether this had any impact on drug testing or patterns of drug use. The health concerns of drug users handing in drug samples at drug testing facilities...

Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.

Progress in neurobiology November 2010 Matthijs G Bossong, Raymond J M Niesink

Cannabis use during adolescence increases the risk of developing psychotic disorders later in life. However, the neurobiological processes underlying this relationship are unknown. This review reports the results of a literature search comprising various neurobiological disciplines, ultimately converging into a model that might explain the neurobiology of cannabis-induced schizophrenia. The...

Instability of the ecstasy market and a new kid on the block: mephedrone

Journal of Psychopharmacology September 8, 2010 Tibor M Brunt, Anneke Poortman, Raymond J.m. Niesink et al. 217 citations

Recently, several reports have indicated instability of the ecstasy market in the Netherlands and other EU countries. In the current study, we demonstrate this instability in the Netherlands, showing a decrease of ecstasy tablets containing 3,4-methylenedioxymetamphetamine (MDMA) by more than 50% in 2009. In addition, we describe a partial replacement of MDMA in tablets sold as ecstasy by a...

mCPP: an undesired addition to the ecstasy market.

Journal of psychopharmacology (Oxford, England) September 2010 M G Bossong, T M Brunt, J P Van Dijk et al.

A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets...

Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature

Drug and Alcohol Review July 1, 2005 Joachim D. Uys, Raymond J.m. Niesink 35 citations

Epidemiological studies show that the use of club drugs is on the rise. Furthermore, the last few decades have seen a rise in patterns of polydrug use. One of the combinations frequently used is ecstasy (MDMA) with gammahydroxybutyrate (GHB). For effective prevention it is important to be aware of this phenomenon and of the pharmacology of these drugs. The effects of the combination extend to...